Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousWhole-Body IrradiationBone and BonesAnemia, AplasticTransplantation ConditioningHematopoietic Stem Cell TransplantationLeukemiaLiver TransplantationTransplantation ChimeraTissue DonorsGraft SurvivalBusulfanBone Marrow PurgingHistocompatibility TestingHematopoietic Stem CellsHistocompatibilityCyclophosphamideTransplantation, IsogeneicBone Marrow DiseasesKidney TransplantationHematopoiesisRecurrenceCombined Modality TherapyMice, Inbred C57BLRadiation ChimeraTreatment OutcomeLeukemia, Myelogenous, Chronic, BCR-ABL PositiveBone Marrow ExaminationLeukemia, Myeloid, AcuteTime FactorsImmunosuppressive AgentsRemission InductionGraft RejectionHematologic NeoplasmsPrecursor Cell Lymphoblastic Leukemia-LymphomaHepatic Veno-Occlusive DiseaseBone RemodelingBone Marrow NeoplasmsTransplantation ImmunologyGraft vs Host ReactionLeukemia, MyeloidImmunosuppressionStem Cell TransplantationLymphocyte DepletionLeukocyte TransfusionLymphoma, Non-HodgkinAcute DiseaseHeart TransplantationRetrospective StudiesSevere Combined ImmunodeficiencyChimeraColony-Forming Units AssaySurvival AnalysisT-LymphocytesHLA AntigensMyelodysplastic SyndromesLung TransplantationActuarial AnalysisHematologic DiseasesCyclosporineBone DensityLymphocyte TransfusionFollow-Up StudiesNuclear FamilyAntineoplastic Combined Chemotherapy ProtocolsCarmustineOrgan TransplantationPancytopeniaGraft vs Tumor EffectCell DifferentiationSurvival RateGraft vs Leukemia EffectLeukocyte CountCytarabineCytomegalovirus InfectionsSpleenBone ResorptionGranulocyte Colony-Stimulating FactorMelphalanMice, Inbred BALB CDisease-Free SurvivalEtoposideFlow CytometryLymphomaMultiple MyelomaCells, CulturedFatal OutcomePrognosisAntigens, CD34Hodgkin DiseasePostoperative ComplicationsMice, KnockoutInfectionCell TransplantationGranulocytes